https://www.forbes.com/sites/alicebroster/2020/04/26/relugolix-combination-therapy-may-be-the-way-to-cope-with-endometriosis-symptoms/#3d16c820589e
Relugolix Combination Therapy May Be The Way To Cope With Endometriosis Symptoms
Endometriosis Treatment Report
www.EndometriosisTreatmentReport.com
https://www.forbes.com/sites/alicebroster/2020/04/26/relugolix-combination-therapy-may-be-the-way-to-cope-with-endometriosis-symptoms/#3d16c820589e
Relugolix Combination Therapy May Be The Way To Cope With Endometriosis Symptoms
Myovant’s Endometriosis Treatment Hits the Mark in First of Two Phase III Trials
Myovant’s Endometriosis Treatment Hits the Mark in First of Two Phase III Trials
https://www.globenewswire.com/news-release/2020/04/22/2019886/0/en/Myovant-Sciences-Announces-Positive-Results-from-Phase-3-SPIRIT-2-Study-Evaluating-Once-Daily-Relugolix-Combination-Therapy-in-Women-with-Endometriosis-and-from-Ovulation-Inhibitio.html
Myovant Sciences Announces Positive Results from Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Endometriosis and from Ovulation Inhibition Study
https://clinicaltrials.gov/ct2/show/NCT03204318?type=Intr&cond=Endometriosis&lupd_s=03%2F22%2F2019&lupd_d=14
Condition : Endometriosis Related Pain
Interventions : Drug: Relugolix; Drug: Estradiol/norethindrone acetate; Drug: Placebo for E2/NETA; Drug: Placebo for relugolix
Sponsor : Myovant Sciences GmbH
Recruiting
SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
NCT03204318
Sun, 02 Jul 2017 12:00:00 EDT
Last Update Posted: 04/05/19 08:45AM